<--- Back to Details
First PageDocument Content
Health / Biotechnology / Biologic License Application / Center for Biologics Evaluation and Research / Biologic / Genentech / Adverse effect / Pharmacology / Medicine / Food and Drug Administration
Health
Biotechnology
Biologic License Application
Center for Biologics Evaluation and Research
Biologic
Genentech
Adverse effect
Pharmacology
Medicine
Food and Drug Administration

DEPARTMENT OF HEALTH & HUMAN

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 51,05 KB

Share Document on Facebook

Similar Documents

Food and Drug Administration / Medicine / Stem cells / Health care / Biology / Transplantation medicine / Good tissue practice / Allotransplantation / Blood / Center for Biologics Evaluation and Research / Cord blood / Tissue

Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products Draft Guidance for Industry and FDA Staff

DocID: 1ogsZ - View Document

Pharmaceutical industry / Food and Drug Administration / Biosimilar / Biotechnology / Drugs / Biologic / Generic drug / Center for Biologics Evaluation and Research / European Medicines Agency / Pharmaceutical sciences / Pharmacology / Clinical research

Microsoft Word - GHLF 50 State Network Biosims Brief TPs FINAL.docx

DocID: 1gkCa - View Document

Pharmacology / Pharmaceutical industry / Biosimilar / Biotechnology / Drugs / Food and Drug Administration / Biologic / Center for Biologics Evaluation and Research / Generic drug / Medicine / Pharmaceutical sciences / Health

  Global  Healthy  Living  Foundation   515  North  Midland  Avenue   Upper  Nyack,  New  York  10960  USA   +1  845  348  0400  

DocID: 1g1KY - View Document

Biotechnology / Food and Drug Administration / Childbirth / Blood banks / Cord blood bank / Transplantation medicine / Cord blood / Current Good Tissue Practices / Center for Biologics Evaluation and Research / Biology / Medicine / Stem cells

Guidance for Industry Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified Indications

DocID: 1fuJJ - View Document

Pharmaceutical sciences / Federal Food /  Drug /  and Cosmetic Act / Structured Product Labeling / Center for Biologics Evaluation and Research / Norfloxacin / Food and Drug Administration / Medicine / Health

DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers Guidance for Industry

DocID: 1aZ0Q - View Document